Screener
Kiniksa Pharmaceuticals International, plc KNSA Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on trailing twelve months.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
FAQ
- What is Kiniksa Pharmaceuticals International, plc's gross margin?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported gross margin of 89.8% in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's gross margin changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's gross margin increased by 4.5% year-over-year, from 85.9% to 89.8%.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's gross margin?
- Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's gross margin has grown at a 3.8% compound annual growth rate (CAGR), from 76.4% to 88.5%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Kiniksa Pharmaceuticals International, plc's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude